Performance and Safety of the Polylactic Interference Screw Used in Anterior Cruciate Ligament Reconstructions

January 14, 2020 updated by: Biomatlante

The evaluation of the clinical data has demonstrated the conformity of the Polylactic Interference Screw (PIS), with the relevant essential requirements for its use in orthopaedic applications. The Polylactic Interference Screws are intended for tibial and femoral ligament/graft fixation in the case or Anterior Cruciate Ligament (ACL) reconstructions. It has been concluded that the risks associated with the use of the device are acceptable when weighted against the benefits to the patients. In order to improve the clinical data on the PIS, the manufacturer, Biomatlante, decided to assess that the performance and safety of the device are maintained until the reaching of its intended use. In this objective, the goal of this study will be to observe the following parameters:

Objective IKDC score (clinical evaluation) Subjective IKDS score (functional evaluation) Safety (report of any adverse event) Follow-up of the patient's recovery

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

56

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Loire
      • Saint-Étienne, Loire, France, 42100
        • Recruiting
        • Centre ORTHEO
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population is considered as all the patients included in the study that meet the inclusion and exclusion criteria.

The study population is composed of 56 patients according to the protocol.

Description

Inclusion Criteria:

  • Acute or chronic Anterior Cruciate Ligament deficiency with complete or partial lesion of the anteromedial bundle requiring primary reconstruction of the Anterior Cruciate Ligament with hamstring tendons
  • Males or females aged from 18 to 60 years
  • No history of surgery on the affected knee
  • Patients not under guardianship or judicial protection
  • Signature of non opposition form (consent of the patient

Exclusion Criteria:

  • History of ligament, meniscal surgery or fracture of the affected knee
  • Pregnancy of breastfeeding women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of the objective International Knee Documentation Committee score before and after surgery
Time Frame: 4 months before surgery / 7 months post-surgery
Record of the objective International Knee Documentation Committee score (A = normal, B = almost normal, C = abnormal or D = very abnormal)
4 months before surgery / 7 months post-surgery
Change of the subjective International Knee Documentation Committee score before and after surgery
Time Frame: 4 months before surgery / 7 months post-surgery
Record of the subjective International Knee Documentation Committee score (from 1 to 100 where 100 is the best result)
4 months before surgery / 7 months post-surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number and precise description of any adverse event during the follow-up
Time Frame: Before surgery until 7 months post-surgery
Record and description of any adverse event during the follow-up that reflects the safety of the Polylactic Interference Screw
Before surgery until 7 months post-surgery
Change in the patients recovery
Time Frame: 2 months post-surgery
Record of specific items of the Objective International Knee Documentation Committee score reflecting the patients recovery
2 months post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: François-Xavier FV VERDOT, M.D., Centre ORTHEO

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 14, 2019

Primary Completion (Anticipated)

October 5, 2021

Study Completion (Anticipated)

October 5, 2021

Study Registration Dates

First Submitted

September 30, 2019

First Submitted That Met QC Criteria

October 8, 2019

First Posted (Actual)

October 10, 2019

Study Record Updates

Last Update Posted (Actual)

January 18, 2020

Last Update Submitted That Met QC Criteria

January 14, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Ligament Injury

Clinical Trials on Anterior Cruciate Ligament Reconstruction

3
Subscribe